openPR Logo
Press release

Sales Revenue of Human Papillomavirus Testing Market to Grow at 7.6% CAGR by 2025

09-20-2017 07:58 AM CET | Health & Medicine

Press release from: Persistence Market Research PVT. LTD.

Sales Revenue of Human Papillomavirus Testing Market to Grow

According to the report, North America’s Human Papillomavirus testing market will be valued at nearly US$ 640 Mn, dominating the global market revenues. The demand for Human Papillomavirus testing will also be significant in Europe, Latin America and Asia-Pacific, while Middle East & Africa’s Human Papillomavirus testing revenues will attribute to less than 4% of global market value.

The report also projects that over 60% of global HPV testing revenues will be accounted by DNA-based test products. While hospitals will be largest end-users of HPV testing globally, the end-use of Human Papillomavirus testing will gain traction in diagnostic centers as well. And, the report also reveals that close to 90% of global Human Papillomavirus testing market value throughout the forecast period will be accounted by molecular diagnostic application of Human Papillomavirus testing.

Various healthcare and government insurance providers are offering reimbursement for diagnosis of chronic disorders such as cervical cancer screening. For instance, Medicare – U.S. government-funded health insurance provider, provides reimbursement to people who are of age 65 or older and some younger population with disabilities.

Moreover, for cervical cancer diagnosis, such plans cover reimbursement for one pap test every three years or a combination of pap test & HPV testing every five years. Favorable government initiatives as such are expected to drive the demand for Human Papillomavirus (HPV) testing market in the years to come.

HPV testing is gradually becoming crucial for cervical cancer screening, according to recent report published by Persistence Market Research. The report estimates that in 2017, the global market for Human Papillomavirus testing will reach an estimated value of US$ 629.4 Mn. Improving reimbursement scenario, coupled with high sensitivity of Human Papillomavirus testing in low resource setting, is expected to drive the market’s growth. By the end of 2025, the global market for Human Papillomavirus testing will have soared at 7.6% CAGR, bringing in more than US$ 1,100 Mn in revenues.

View and Download TOC of Human Papillomavirus (HPV) Testing Market Research Report@ https://www.persistencemarketresearch.com/market-research/human-papillomavirus-testing-market/toc

A key limitation for Human Papillomavirus testing is that these tests are confined to women as men undergoing HPV testing have higher risks of getting infected with genital warts. In addition to this, patients are not willing to take Human Papillomavirus tests because of lack of diagnosis options. Over-diagnosis of Human Papillomavirus testing can cause more complications and can even risk the life of patients.

Meanwhile, the global revenues from Human Papillomavirus testing are being lowered due to availability of HPV vaccines. Preference to HPV vaccines is directly impeding the revenues arising from Human Papillomavirus testing. High cost of HPV screening test, overburdened healthcare system, low awareness on HPV prevention, and imperfections in organized screening programs are some other challenges impacting the growth of global HPV testing market.

Request and Download Sample Report@ https://www.persistencemarketresearch.com/samples/11737

The report further profiles key players in the global Human Papillomavirus testing market, which include F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Becton, Dickinson and Company, Qiagen N.V., Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Cepheid Inc., Seegene Inc., Takara Bio Inc., DaAn Gene Co., Ltd. of Sun Yat-Sen University, Promega Corporation, Greiner Bio-One International GmbH (Greiner Holding AG), Enzo Biochem Inc., Norgen Biotek Corp., DiagCor Bioscience Inc Ltd, Hybribio Limited, Zytovision GmbH, Arbor Vita Corporation, Medical & Biological Laboratories Co., Ltd. and Fujirebio Diagnostics, Inc.

Buy Full Human Papillomavirus (HPV) Testing Market Report@ https://www.persistencemarketresearch.com/checkout/11737

About Us

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353

Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sales Revenue of Human Papillomavirus Testing Market to Grow at 7.6% CAGR by 2025 here

News-ID: 727689 • Views:

More Releases from Persistence Market Research PVT. LTD.

Battery Material Market is projected to reach a valuation of US$ 110.02 billion by 2027
Battery Material Market is projected to reach a valuation of US$ 110.02 billion …
The battery material market has witnessed significant growth in recent years, driven by the increasing demand for batteries in various applications. According to recent studies, the market was valued at USD 42.1 billion in 2022 and is projected to reach USD 110.02 billion by 2027, growing at a CAGR of 14.1% during the forecast period. Click Here to Get Free Sample Copy of this Report@https://www.persistencemarketresearch.com/samples/10801 The battery material market encompasses a wide
Automated Intralogistics Material Handling Solutions Market to Hit US$ 219.3 billion by 2033
Automated Intralogistics Material Handling Solutions Market to Hit US$ 219.3 b …
Automated intralogistics material handling solution sales are anticipated to achieve a global market value of US$ 55.9 billion in 2023 and to grow steadily at a CAGR of 14.8% to reach US$ 219.3 billion by 2033. The global intralogistics material handling solutions market is experiencing a revolution with the introduction of automated systems. Automation has become a game-changer, offering greater efficiency and productivity to businesses across the globe. The market for automated intralogistics material handling solutions is projected to witness impressive growth in the coming years. Click Here to Get Free Sample Copy of this Report@https://www.persistencemarketresearch.com/samples/32829 The key drivers for the growth of the automated intralogistics material handling
Cold Chain Market is Encouraged to Reach USD 474.29 billion by 2028
Cold Chain Market is Encouraged to Reach USD 474.29 billion by 2028
The global cold chain market size was valued at USD 211.77 billion in 2020 and is expected to reach USD 474.29 billion by 2028, growing at a CAGR of 9.7% from 2021 to 2028. The growth is driven by increasing demand for perishable goods, globalization of the food trade, and technological advancements in cold chain logistics. Click Here to Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3177 The cold chain market refers
Automated Intralogistics Material Handling Solutions Market Value to Hit US$ 219.3 Bn by 2033
Automated Intralogistics Material Handling Solutions Market Value to Hit US$ 219 …
𝐀𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐈𝐧𝐭𝐫𝐚𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥 𝐇𝐚𝐧𝐝𝐥𝐢𝐧𝐠 𝐒𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧 𝟐𝟎𝟐𝟑, 𝐬𝐚𝐥𝐞𝐬 𝐨𝐟 𝐚𝐮𝐭𝐨𝐦𝐚𝐭𝐞𝐝 𝐢𝐧𝐭𝐫𝐚𝐥𝐨𝐠𝐢𝐬𝐭𝐢𝐜𝐬 𝐦𝐚𝐭𝐞𝐫𝐢𝐚𝐥 𝐡𝐚𝐧𝐝𝐥𝐢𝐧𝐠 𝐬𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐠𝐥𝐨𝐛𝐚𝐥 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐬 𝐞𝐱𝐩𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐔𝐒$ 𝟓𝟓.𝟗 𝐁𝐧 𝐚𝐧𝐝 𝐢𝐬 𝐩𝐫𝐨𝐣𝐞𝐜𝐭𝐞𝐝 𝐭𝐨 𝐞𝐱𝐩𝐚𝐧𝐝 𝐬𝐭𝐞𝐚𝐝𝐢𝐥𝐲 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟏𝟒.𝟖% 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 𝐚 𝐦𝐚𝐫𝐤𝐞𝐭 𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐨𝐧 𝐨𝐟 𝐜𝐥𝐨𝐬𝐞 𝐭𝐨 𝐔𝐒$ 𝟐𝟏𝟗.𝟑 𝐁𝐧 𝐛𝐲 𝟐𝟎𝟑𝟑. The demand in Germany is expected to increase by 15.7% CAGR from 2024 to 2033 on a value basis. U.S., China, and Germany are the leading countries in the

All 5 Releases


More Releases for Human

I AM HUMAN
Camerata Europæa (CE), inspired by the kaleidoscope of unique current events in the world, presents a cultural program for the year 2022/23 under the motto I AM HUMAN. New perceptions, new morals, new technologies, and ultimately a whole new world, shape modern man. With the progress of science and the evolution of technology, man has comprehended previously unimaginable concepts, marking great and admirable achievements. However, the powerful mechanisms of modern
The Human Whisperer
'The Human Whisperer' Finlay McArthur Published in Austin Macauley Publishers Ltd on 30th of June 2020, both in paperback and eBook version. The Human Whisperer is the second book by Finlay on his quest to give his readers a better understanding of life. This book will help the reader understand that as humans, there is so much more to us than we think. We are connected to the world both physically and
Human Physiology 2019
Human Physiology 2019 Theme: Exploring the Principles of Physiology & Metabolism September 16-17, 2019 | London, United Kingdom Lexis Conferences cordially invites all the members of different nations to attend this annual meet which is scheduled to hold on September 16-17, 2019 at London, United Kingdom based on theme Exploring the Principles of Physiology & Metabolism. A two days scientific meet will gather scientists, students and healthcare industries under one roof to build
Building A Better Human: The Future Of Human Augmentation
Market Scenario: Human augmentation is usually used to denote technologies that enhance human efficiency or capability, that in some way add to the human body. Technological advancements in many areas of IT have directed to a greater variety of implants and other technologies that can be classed as human augmentation.Human augmentation may also be named human 2.0. Within the greater group of human augmentation technologies, some diverse classifications can be made.
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our
Human Microbiome Market
Microbial cells outnumber the human cells in the ratio 10:1 in a health human body. Human microbiome is the study of microbes present in the human body. These are beneficial microbes that carry out functions not performed by any gene in the human DNA and hence, they play a very important role in the human body. For example, these microbes produce certain vitamins that our body cannot make, breakdown our